Process intensification (PI) enhances the efficiency, flexibility, and sustainability of complex molecule manufacturing by reducing costs and increasing throughput. That is why the monoclonal antibody ...

Innovative bioprocessing technologies are needed to make monoclonal antibody (mAb) production cheaper, according to new research, which suggests lowering the cost of goods (COGs) for mAb-based ...

The long journey from cell culture to a purified monoclonal antibody (mAb) involves many sample processing steps, with clarification and filtration playing significant roles. However, clogs, complex ...

Monoclonal antibodies (mAbs) have revolutionized cancer therapy due to their ability to specifically target tumor cells while sparing healthy ones. These biologics have become indispensable in ...